An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Transforming the Management of Acute Lymphoblastic Leukemia 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Oral Targeted Therapies in Relapsed/Refractory Acute Myeloid Leukemia 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Chronic Myeloid Leukemia: De-Escalation of TKI Therapy 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Managing Toxicities of Outpatient Oral Therapies for Chronic Myeloid Leukemia 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
The Role of Clonal Hematopoiesis in Hematologic Malignancies 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Evolving Treatment Strategies in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma 1.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Outpatient Administration of Bispecific Antibodies and CAR T-Cell Therapies 1.00 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Managing Toxicities of Bispecific Antibodies and CAR T-Cell Therapies in the Outpatient Setting 1.25 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Working Toward Unified Classification of Hematolymphoid Malignancies 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Current and Emerging Treatment Options for Peripheral T-Cell Lymphomas 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Chronic Lymphocytic Leukemia: Navigating First-Line and MRD-Guided Treatment Options 0.75 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Optimizing Treatment for Relapsed/Refractory Follicular Lymphoma 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Evolving Strategies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma 0.50 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm
Update on the Diagnosis and Management of Marginal Zone Lymphomas 0.50 11/02/2026 - 12:00am to 11/15/2027 - 11:59pm
Collaborative Strategies for Optimizing Small-Volume Drug Delivery 0.75 11/02/2026 - 12:00am to 11/01/2027 - 11:59pm

Pages